Pacific Biosciences

PacBio is in it for the long run
PacBio is in it for the long run
EP Vantage
Pacific Biosciences
DNA sequencing
Illumina
Medtech
Flag link:
PacBio’s $600M Omniome buyout brings together long & short of DNA sequencing
PacBio’s $600M Omniome buyout brings together long & short of DNA sequencing
MedCity News
Pacific Biosciences
Omniome
DNA sequencing
M&A
Flag link:
10 of the Most Controversial Deals in Medtech
10 of the Most Controversial Deals in Medtech
Medical Devices and Diagnostics Industry
devices
Medtech
M&A
FTC
Illumina
Pacific Biosciences
Google
Fitbit
HeartWare
Thoratec
Strkyer
Wright Medical
Organovo
Tarveda Therapeutics
Thermofisher
Qiagen
Second Sight Medical
Pixium Vision
Medtronic
Covidien
Grail
Abbott Labs
Alere
Flag link:
This Biotech Just Made History. Will Its Stock Follow?
This Biotech Just Made History. Will Its Stock Follow?
Motley Fool
gene sequencing
Pacific Biosciences
Flag link:
2 Winners for a Drug Development Future That Looks Nothing Like the Past
2 Winners for a Drug Development Future That Looks Nothing Like the Past
Motley Fool
genomics
Pacific Biosciences
Beam Therapeutics
Flag link:
How Pacific Biosciences Beat Expectations in Q4
How Pacific Biosciences Beat Expectations in Q4
Motley Fool
Pacific Biosciences
earnings
Flag link:
A year after FTC nixed Illumina buyout, SoftBank bets $900M on PacBio's new vision
A year after FTC nixed Illumina buyout, SoftBank bets $900M on PacBio's new vision
Endpoints
Pacific Biosciences
Illumina
SoftBank
M&A
Flag link:
Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 Results
Why Pacific Biosciences of California Hit a Speed Bump With Its Q3 Results
Motley Fool
Pacific Biosciences
M&A
Flag link:
What's Behind Pacific Biosciences of California's Ugly Q2 Results?
What's Behind Pacific Biosciences of California's Ugly Q2 Results?
Motley Fool
Pacific Biosciences
earnings
Flag link:
Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire
Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire
Xconomy
gene sequencing
Pacific Biosciences
Pharma CEOs
Flag link:
Here’s Why Illumina Shares Barely Budged When It Gave Up On Its Takeover to The Tune Of $98 Million
Here’s Why Illumina Shares Barely Budged When It Gave Up On Its Takeover to The Tune Of $98 Million
Motley Fool
Illumina
Pacific Biosciences
M&A
Flag link:
Illumina scraps $1.2B PacBio takeover amid regulatory pushback
Illumina scraps $1.2B PacBio takeover amid regulatory pushback
BioPharma Dive
Illumina
Pacific Biosciences
M&A
Flag link:
What Happens Next for Illumina and Pacific Biosciences?
What Happens Next for Illumina and Pacific Biosciences?
Motley Fool
Illumina
Pacific Biosciences
M&A
Flag link:
The FTC moves to block DNA sequencer Illumina’s acquisition of PacBio, calling company a ‘monopolist’
The FTC moves to block DNA sequencer Illumina’s acquisition of PacBio, calling company a ‘monopolist’
Stat
FDA
DNA sequencing
Illumina
Pacific Biosciences
M&A
Flag link:
Merger or Not, Pacific Biosciences Needs to Deliver
Merger or Not, Pacific Biosciences Needs to Deliver
Motley Fool
Pacific Biosciences
DNA sequencing
Flag link:
Here's Why Pacific Biosciences Is Tumbling Today
Here's Why Pacific Biosciences Is Tumbling Today
Motley Fool
Pacific Biosciences
Europe
patents
DNA sequencing
Flag link:
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Illumina Reports Its Q1 Results on Thursday: 3 Things You Can Expect
Motley Fool
Illumina
earnings
Pacific Biosciences
Flag link:
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Pump the Brakes on the Illumina and Pacific Biosciences Deal
Motley Fool
Illumina
Pacific Biosciences
DNA sequencing
M&A
Flag link:
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Flag link:
Illumina taking out Pacific Biosciences for $1.2B
Illumina taking out Pacific Biosciences for $1.2B
BioCentury
Illumina
Pacific Biosciences
M&A
genomics
Flag link:

Pages